Botulinum toxin-a treatment reduces human mechanical pain sensitivity and mechanotransduction
The mechanisms underlying the analgesic effects of botulinum toxin serotype A (BoNT-A) are not well understood. We have tested the hypothesis that BoNT-A can block nociceptor transduction. Intradermal administration of BoNT-A to healthy volunteers produced a marked and specific decrease in noxious m...
Main Authors: | Paterson, K, Lolignier, S, Wood, J, McMahon, S, Bennett, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
John Wiley and Sons Inc.
2014
|
Similar Items
-
Botulinum toxin-A treatment reduces human mechanical pain sensitivity and mechanotransduction.
by: Paterson, K, et al.
Published: (2014) -
BOTULINUM TOXIN FOR PAIN SYNDROMES
by: E. Kostenko, et al.
Published: (2018-02-01) -
Botulinum Toxin for the Treatment of Neuropathic Pain
by: JungHyun Park, et al.
Published: (2017-08-01) -
Mechanisms of Botulinum Toxin Type A Action on Pain
by: Ivica Matak, et al.
Published: (2019-08-01) -
Botulinum toxin in the treatment of neuralgia and neuropathic pain
by: Katarzyna Mielniczek
Published: (2021-09-01)